SL Therapeutics, Inc. is based in South Korea, with the head office in Seoul. The enterprise operates in the Research and Development in Nanotechnology industry. SL Therapeutics, Inc. was incorporated on April 10, 2026. SL Therapeutics, Inc. currently employs 6 (2023) people. There was a net sales revenue increase of 89.66% reported in SL Therapeutics, Inc.’s latest financial highlights for 2023. Over the same period, its total assets decreased by 34.82%. In 2023, SL Therapeutics, Inc.’s net profit margin increased by 845.85%.
Headquarters
711 Techno Complex Of Korea University 145 Anam-Dong, Sungbuk-Gu, Seoul 136-701, Korea
Seoul; Seoul;
Contact Details: Purchase the SL Therapeutics, Inc. report to view the information.
Website: http://www.stemlab.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service